PhRMA's Conversations bring together advocates, patients and stakeholders for thoughtful discussions on health care's biggest issues.

How can we assure that the 340B program provides access to discounted medicines to the indigent and vulnerable patients the program was designed to serve?

Select a Contributor Response:

Subscribe to PhRMA email updates: